rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Anastasios Gianakakos

President & CEO

Company insider

Files Form 4 as: President & CEO, Kardigan; Director, LianBio; President and CEO, MyoKardia; SVP, Chief Business Officer, MAP Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
575
Buys
3
Sells
96
Bought
$133K
Sold
$17.6M
Companies
4
Companies where not an officer
1
First trade
22 Jan 2008
Last trade
17 Jun 2026
Last filed
22 Jun 2026

Companies traded

Where they are an officer
KARD KardiganDirector, Officer · Biotechnology · last 17 Jun 20260 buys · 0 sells
MyoKardiaDirector, Officer · last 17 Nov 20203 buys · 49 sells
MAP PharmaceuticalsOfficer · last 1 Mar 20130 buys · 47 sells
Everywhere else they filed: board seats, 10% stakes, other companies
LianBioDirector · last 15 Feb 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 22 Jun 2026KARD KardiganBiotechnologySEC FORM 4 Code C—28,702filing
17 Jun 2026filed 22 Jun 2026KARD KardiganBiotechnologySEC FORM 4 Code C—41,001filing
17 Jun 2026filed 22 Jun 2026KARD KardiganBiotechnologySEC FORM 4 Code C—498,692filing
17 Jun 2026filed 22 Jun 2026KARD Kardiganoption or derivative · BiotechnologySEC FORM 4 Code C—18,020filing
17 Jun 2026filed 22 Jun 2026KARD Kardiganoption or derivative · BiotechnologySEC FORM 4 Code C—25,742filing
17 Jun 2026filed 22 Jun 2026KARD Kardiganoption or derivative · BiotechnologySEC FORM 4 Code C—313,092filing
17 Jun 2026filed 22 Jun 2026KARD Kardiganoption or derivative · BiotechnologySEC FORM 4 Code C—18,020filing
17 Jun 2026filed 22 Jun 2026KARD Kardiganoption or derivative · BiotechnologySEC FORM 4 Code C—25,742filing
17 Jun 2026filed 22 Jun 2026KARD Kardiganoption or derivative · BiotechnologySEC FORM 4 Code C—313,092filing
17 Jun 2026filed 22 Jun 2026KARD KardiganBiotechnologySEC FORM 4 Code C—28,702filing
17 Jun 2026filed 22 Jun 2026KARD KardiganBiotechnologySEC FORM 4 Code C—41,001filing
17 Jun 2026filed 22 Jun 2026KARD KardiganBiotechnologySEC FORM 4 Code C—498,692filing
15 Feb 2024filed 20 Feb 2024LianBiooption or derivativeSEC FORM 4 Code M—36,300 at $0.00filing
15 Feb 2024filed 20 Feb 2024LianBioSEC FORM 4 Code M$91K36,300 at $2.52filing
15 Feb 2024filed 20 Feb 2024LianBioSEC FORM 4 Code F$91K19,218 at $4.76filing
21 Jun 2023filed 23 Jun 2023LianBiooption or derivativeSEC FORM 4 Code A—36,300 at $0.00filing
23 Jun 2022filed 27 Jun 2022LianBiooption or derivativeSEC FORM 4 Code A—36,300 at $0.00filing
29 Dec 2021filed 3 Jan 2022LianBiooption or derivativeSEC FORM 4 Code M—36,548 at $0.00filing
29 Dec 2021filed 3 Jan 2022LianBioSEC FORM 4 Code M$237K36,548 at $6.49filing
17 Nov 2020filed 19 Nov 2020MyoKardiaoption or derivativeSEC FORM 4 Code D—149,517filing

The newest 500 lines are listed; the numbers count every line.

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed99

Buys in green, sells in red, by the company’s sector.

Related people

Kristin Marie K. ReinkeDirector · Director at Kardigan, filing Form 4 there in the last year
Joseph EdelmanDirector · Director at Kardigan, filing Form 4 there in the last year
PERCEPTIVE ADVISORS LLCDirector · Director at Kardigan, filing Form 4 there in the last year
Paul L. BernsDirector and Officer · Director and 10% owner at Kardigan, filing Form 4 there in the last year
HRTG GPE, LLC10% owner · 10% owner at Kardigan, filing Form 4 there in the last year